CDT Equity Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.9M
- Price
- $3.00
- % Change (Daily % change from the live per-ticker quote feed.)
- +3.45%
- Volume
- 28.8K
About
Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.
Quick stats
Shares outstanding631.1K
Computed float110.1K
Float / shares17.4%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001896212
Websitehttps://www.cdtequity.com
AI Summary
AI-generated1/29
standardbullishm and a
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
CDT Equity announced it will increase its equity stake in Sarborg Limited to 22.7% through the issuance of pre-funded warrants for up to 12.1 million shares, pending shareholder approval at the annual meeting on August 28.
Sarborg, an agentic AI business, has expanded its Signature Intelligence platform into quantum computing via SarborgQ and broadened its IP portfolio into agriculture, supporting an implied valuation of approximately $638.3 million.
CEO Dr. Andrew Regan emphasized that the transaction strengthens strategic alignment with Sarborg and represents a compelling opportunity to create long-term shareholder value.
Red flags
- Transaction is contingent on shareholder approval on August 28, 2026
- Consideration involves issuance of pre-funded warrants, implying dilution for existing CDT shareholders